COMPARISON OF CLINICAL FEATURES AND SURVIVAL BETWEEN YOUNG AND OLD CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A SINGLE CENTRE STUDY FROM TURKEY

EHA Library, Rafet Eren, 216290

DESIGN, SYNTHESIS, ANTI-PROLIFERATIVE, CELL CYCLE INHIBITORY AND IN-VIVO ANTILEUKEMIC ACTIVITY OF NOVEL THIAZOLIDINEDIONES IN COMBINATION WITH IMATINIB.

EHA Library, Hardik Joshi, 216291

EFFECTS OF DIFFERENT TKIS ON CHRONIC MYELOID LEUKEMIA STEM CELLS AND TKIS DISCONTINUATION

EHA Library, Lin Jiang, 216292

ASSOCIATION OF PLK1 AND AURORA KINASE INHIBITORS WITH WEE1 INHIBITORS: A NOVEL THERAPEUTIC APPROACH FOR BLAST CRISIS CML

EHA Library, Manuela Mancini, 216293

WNT PATHWAY IS INVOLVED IN BCR-ABL1-INDEPENDENT RESISTANCE TO TKIS IN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Susanna Grassi, 216294

AVOIDING BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKEMIA CELLS BY CRISPR/CAS9 SYSTEM GENOME EDITION TOOL.

EHA Library, Verónica Alonso-Pérez, 216295

OUTCOME OF FRONTLINE TREATMENT WITH GENERIC OF IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Samia menif, 216296

MTORC2 COMPLEX SUSTAINS LEUKEMIC STEM CELL SELF-RENEWAL BY NUCLEAR RELOCALIZATION OF ITS COMPONENTS

EHA Library, Cristina Panuzzo, 216297

THE ROLE OF LEUKEMIC STEM CELLS AND EARLY PROGENITOR CELLS IN CHRONIC MYELOGENOUS LEUKEMIA RECURRENCE AFTER THE DISCONTINUATION OF TREATMENT WITH TKI

EHA Library, Tetiana Perekhrestenko, 216298

SALIVARY PROTEOMIC PROFILE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA DISTINGUISHES TKIS RESPONDERS FROM NON-RESPONDERS

EHA Library, Francesca Perutelli, 216299

MYOFIBROBLASTS DERIVED FROM CHRONIC MYELOGENOUS LEUKEMIA PATIENTS EXPRESSED BCR-ABL TRANSCRIPT WHEN CULTURED WITH INTERLEUKIN-1 BETA

EHA Library, Naoki Shirafuji, 216300

BEX1 GENE EXPRESSION IS A PREDICTOR FOR THE RESPONSE TO NILOTINIB IN CHRONIC MYELOGENOUS LEUKEMIA

EHA Library, Dong-Yeop Shin, 216301

NILOTINIB VS IMATINIB IN ALBANIAN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE.

EHA Library, Alma Cili, 216302

ALTERED EXPRESSION OF JAK-STAT PATHWAY AS POSSIBLE PREDICTIVE MARKER IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA RECEIVING TYROSIN KINASE INHIBITORS (TKIS)

EHA Library, Susanna Grassi, 216303

BCR-ABL EXON 7 DELETION CAUSES TKI RESISTANCE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA


EHA Library, Ilya Mikhailov, 216304

LW-213 TRIGGERED G2/M CELL CYCLE ARREST AND APOPTOSIS OF CHRONIC MYELOGENOUS LEUKEMIA CELLS THROUGH SUPPRESSION OF CDK9-RELATED SIGNALING PATHWAYS

EHA Library, Jingyan XU, 216305

DOWN-REGULATION OF MUSASHI2 AFFECTS ON MTOR SIGNALING AND INDUCES APOPTOSIS IN CD34+ CHRONIC MYELOID LEUKEMIA CELLS

EHA Library, Majid Mossahebi-mohammadi, 216306

HLA CLASS I AND CLASS II ALLELE FREQUENCIES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND THEIR EFFECT ON SURVIVAL

EHA Library, Isik Kaygusuz Atagunduz, 216307

LONG-TERM OUTCOMES OF EARLY CP CML PATIENTS WHO HAVE ACHIEVED CCYR BUT NOT MMR AFTER 24 MONTHS ON FRONTLINE IMATINIB THERAPY

EHA Library, Sung-Hyun Kim, 216308

INTERDISCIPLINARY APPROACH FOR THE MANAGEMENT OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Jon Badiola, 216309

EVALUATION OF LOW LEVEL DETECTION OF MAJOR BCR-ABL1 MRNA IN CHRONIC MYELOID LEUKEMIA (DOMEST ADDITIONAL STUDY)

EHA Library, Hiroaki Kitamura, 216310

TREATMENT- FREE REMISSION UP TO 12 YEARS. INTERIM ANALYSIS OF A REGIONAL GERMAN CML - REGISTER. (A CONTRIBUTION OF GERMAN CML - ALLIANCE)

EHA Library, Dietrich KÄMPFE, 216311

GASTRIC CONDITIONS AS PROXY FOR HELICOBACTER PYLORI INFECTION AND RISK OF CHRONIC MYELOID LEUKEMIA

EHA Library, Gunnar Larfors, 216312

AN APPROACH TO DRUG-TO-DRUG INTERACTIONS IN CML PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS. AN OBSERVATIONAL STUDY OF THE SPANISH CML GROUP (GELMC).

EHA Library, Ignacio Gómez-Centurión, 216313

IMATINIB TREATMENT IN ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) IN THE REAL-LIFE SETTING: UPDATED DATA OF THE CERRAHPASA CML COHORT

EHA Library, Deniz Ozmen, 216314

COMPARISON OF MOLECULAR RESPONSES AND OUTCOMES IN CHRONIC MYELOID LEUKEMIA – CHRONIC PHASE PATIENTS TREATED WITH NILOTINIB INITIALLY FOLLOWED BY IMATINIB, COMPARED TO TREATMENT WITH IMATINIB UPFRONT

EHA Library, Aditi Jain, 216315

EVALUATION OF THE CEPHEID XPERT® BCR-ABL ULTRA ASSAY¥ IN CLINICAL SPECIMENS IN COMPARISON TO THE QIAGEN® IPSOGEN BCR-ABL1 MBCR IS-MMR ASSAY

EHA Library, Gwo-Jen Day, 216316

EFFICACY AND SAFETY OF SWITCHING FROM BRANDED TO GENERIC IMATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: A STUDY OF THE GRUPPO TRIVENETO LMC ON 294 PATIENTS

EHA Library, Massimiliano BONIFACIO, 216317

FREQUENCY OF GATEKEEPER MUTATION IN THE NON-RESPONDING CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Bushra Kaleem, 216318

THE RESTORING OF DEEP MOLECULAR RESPONSE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND MOLECULAR RELAPSE AFTER TREATMENT DISCONTINUATION

EHA Library, Ekaterina Chelysheva, 216319

REAL-WORLD EVIDENCE OF MOLECULAR RESPONSE TO TYROSINE KINASE INHIBITORS FROM CHINA SUPPORTS EUROPEAN LEUKEMIANET 2013 RECOMMENDATIONS FOR THE MANAGEMENT OF CHRONIC MYELOID LEUKAEMIA.

EHA Library, Hua YIN, 216320

MATHEMATICAL MODELLING REVEALS THE POTENTIAL FOR CONSIDERABLE DOSE REDUCTIONS IN TYROSINE KINASE INHIBITOR TREATED CHRONIC MYELOID LEUKEMIA

EHA Library, Ingo Roeder, 216321

IMPROVING EUTOS SCORE SENSITIVITY BY USING SERUM ALPHA/BETA TRYPTASE-1 LEVEL IN NEWLY DIAGNOSED EGYPTIAN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA IN CORRELATION TO THE MOLECULAR MILSTONES

EHA Library, Ayman Youssef, 216322

ADDITIONAL CYTOGENETIC ABNORMALITIES IN CHRONIC MYELOID LEUKEMIA; EXPERIENCE FROM PAKISTAN

EHA Library, Nida Anwar, 216323

ANALYSIS OF SERUM LIPIDS, CARDIOVASCULAR RISK AND INDICATION FOR STATIN THERAPY AT THE START AND DURING IMATINIB AND NILOTINIB THERAPY IN DE NOVO CML PATIENTS– RESULTS FROM REAL-LIFE PROSPECTIVE STUDY

EHA Library, Tomáš Horňák, 216324

PROGNOSTIC ROLE OF REBOUND BASOPHILIA DURING CYTOREDUCTION IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA

EHA Library, Lucia Vrablova, 216325

CARDIOVASCULAR EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB

EHA Library, Anastasia Bykova, 216326

DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN PORTUGUESE CML PATIENTS: A SINGLE INSTITUTE EXPERIENCE

EHA Library, Nuno Cerveira, 216327

THE HIGHER THE DOSE OF DASATINIB, THE LOWER THE MOLECULAR RESPONSES AS WELL AS THE GREATER THE DOSE-LIMITING TOXICITIES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Jangik Lee, 216328

MYELOID-DERIVED SUPPRESSOR CELLS IN CHRONIC MYELOID LEUKEMIA

EHA Library, Ari Ahn, 216329

MORE THAN 10-YEARS SURVIVORS WITH CHRONIC MYELOID LEUKEMIA WITHOUT ANY MOLECULAR RESPONSE - REAL LIFE EVIDENCE FROM A SINGLE INSTITUTION

EHA Library, Gueorgui Balatzenko, 216330

EARLY AND SUSTAINED DEEP MOLECULAR RESPONSE OF NILOTINIB AS A FRONTLINE THERAPY IN HIGH SOKAL RISK CML PATIENTS

EHA Library, uzma zaidi, 216331

DEVELOPMENT OF SAMPLE PREPARATION PROCEDURE FOR TESTING SPECIMENS WITH HIGH WHITE BLOOD CELL COUNTS FOR XPERT® BCR-ABL ULTRA¥

EHA Library, Gwo-Jen Day, 216332

CHRONIC MYELOID LEUKEMIA WITH ISOLATED THROMBOCYTOSIS WITHOUT SIGNIFICANT LEUKOCYTOSIS IS A SUBTYPE OF CHRONIC MYELOID LEUKEMIA WITH DISTINCT DISEASE CHARACTERISTICS

EHA Library, Yuka Sugimoto, 216333

IMPACT OF BCR-ABL TYROSINE KINASE INHIBITORS ON THE SURVIVAL AND FUNCTIONS OF ENDOTHELIAL CELLS

EHA Library, Hélène Haguet, 216334

LATE MYOCARDIAL TOXICITY IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS ON LONG-TERM TYROSINE KINASE INHIBITOR (TKI) THERAPY

EHA Library, Leanne Genge, 216335

COMORBIDITY INDEX RELATED OUTCOME IN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Irena Cojbasic, 216336

REAL-WORD DATA FROM LONG TERM FOLLOW-UP OF IMATINIB INITIALLY TREATED CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Irena Cojbasic, 216337

A STUDY TO IDENTIFY THE POPULATION VARIATION IN THE RESPONSE AND THE SIDE EFFECT PROFILE IN CHRONIC MYELOID LEUKEMIA - A NATIONAL EXPERIENCE FROM SRI LANKA

EHA Library, Ovini GAMAGE, 216338

THE SIGNIFICANCE OF VERY EARLY MOLECULAR RESPONSE WITH FRONTLINE DASATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS AS A STRONG PREDICTOR OF LONG-TERM OUTCOME: FINAL ANALYSIS OF PCR-DEPTH STUDY

EHA Library, Won Sik Lee, 216339

NILOTINIB IN 161 PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE AFTER IMATINIB RESISTANCE OR INTOLERANCE: “LA RAZA” NATIONAL MEDICAL CENTER EXPERIENCE

EHA Library, Manuel Ayala, 216340

INTOLERANCES AND HOSPITALIZATIONS AFTER 1, 3 AND 5 YEARS OF TKI THERAPY IN SIMPLICITY, A STUDY OF CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA PATIENTS IN ROUTINE CLINICAL PRACTICE

EHA Library, Michael J. Mauro, 216341

RESULTS OF GENERIC IMATINIB TREATMENT IN SOKAL INTERMEDIATE & HIGH RISK CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS IN RESOURCE-CONSTRAINED SETTING: A SINGLE-CENTER EXPERIENCE FROM NORTH INDIA

EHA Library, Uttam Kumar Nath, 216342

QUALITY OF LIFE IN CHRONIC MYELOID LEUKEMIA PATIENTS RECEIVING A TYROSINE KINASE INHIBITOR

EHA Library, Eren Gunduz, 216344

THE EVALUATION OF THE TOTAL ANTIOXIDANT CAPACITY IN RELATION TO THE TREATMENT WITH TYROSIN-KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA

EHA Library, Mihnea-Alexandru Găman, 216345

HIGH DIVERSITY IN THE SEQUENTIAL TREATMENT WITH TKI’S OF CML. A LONG-TERM, REAL LIFE ANALYSIS OF THE SPANISH REGISTRY OF CML (RELMC)

EHA Library, Luis Felipe CASADO MONTERO, 216346

SOMATIC MUTATIONS IN PATIENTS WITH CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE, MYELODYSPLASTIC SYNDROME AND RELATED MYELOID NEOPLASMS: A PRELIMINARY STUDY WITH A NORTHEASTERN POPULATION IN BRAZIL

EHA Library, Luciene Oliveira, 216347

THE HYPERMETHYLATION PROFILE OF APOPTOTIC GENES IN MYELODYSPLASTIC SYNDROMES

EHA Library, Farhad ZAKER, 216348

THE ANALYSIS OF EXPRESSION OF FOXP3 MOLECULE’S ISOFORMS BY REGULATORY Т CELLS IN PERIPHERAL BLOOD IN MYELODYSPLASTIC SYNDROME PATIENTS

EHA Library, Galina Dudina, 216349

GENE EXPRESSION AND EPIGENETIC PROFILING SEPARATES CASES WITH DIC(1;7)(Q10;P10) FROM T-MDS/AML

EHA Library, Anair Graciela Lema Fernandez, 216350

TARGET NEXT GENERATION SEQUENCING FOR SOMATIC MUTATION SCREENING IN PATIENTS WITH A LOWER-RISK MDS TREATED WITH THE IRON-CHELATOR DEFERASIROX

EHA Library, Emiliano Fabiani, 216351

VARIATION IN THE LEVEL OF AKT1 IN LYSATES OF BONE MARROW CELLS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Natallia Klimkovich, 216352

TREG LEVELS IN BONE MARROW OF LOW RISK MDS PATIENTS CORRELATE WITH PREFERENTIAL EXPANSION OF CYTOTOXIC T CELLS IN BONE MARROW AND A MORE FAVOURABLE PROGNOSIS.

EHA Library, Stefania Leone, 216353

A SINGLE CENTRE EXPERIENCE OF RESPONSE RATES TO AZACITIDINE FOR MDS, AML AND CMML IN RELATION TO CYTOGENETICS RISK AND PERFORMANCE STATUS

EHA Library, Vidhya Murthy, 216354

CHILDHOOD SECONDARY MYELODYSPLASTIC SYNDROME – CASE REPORT OF A RARE DIAGNOSIS

EHA Library, Medeiros Julia, 216355

THE HIDDEN IMPACT OF PATIENT GENERAL CONDITION ON THE OVERALL SURVIVAL OF MYELODYSPLASTIC SYNDROMES AND RELATED DISEASES (CHRONIC MYELOMONOCYTIC LEUKEMIA AND ACUTE MYELOID LEUKEMIA)

EHA Library, Paola González Carmona, 216356

CHRONIC MYELOMONOCYTIC LEUKEMIA AND AUTOIMMUNE DISORDERS

EHA Library, Gustavo Alberto PINTO SOLANO, 216357

NEXT GENERATION SEQUENCING IN PREDICTING OUTCOME IN MDS- DAWN OF NEW ERA IN PAKISTAN

EHA Library, Nida Anwar, 216358

ACCESS TO DIAGNOSTIC AND THERAPEUTIC TOOLS FOR MYELODYSPLASTIC SYNDROMES IN GENERAL PRACTICE: SURVEY AMONG LATIN-AMERICAN HEMATOLOGISTS

EHA Library, Renee Crisp, 216359

DEVELOPING A CORE OUTCOME SET FOR MYELODYSPLASTIC SYNDROMES – THE MDS-RIGHT HEALTH PROFESSIONAL DELPHI SURVEY

EHA Library, Igor Stojkov, 216360

DEPLETION OF PROGENITORS B CELLS IN CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Gustavo Alberto PINTO SOLANO, 216361

ASSEMENT OF TRANSFUSION FREQUENCY AS A MORTALITY INDICATOR IN MYELODYSPLASTIC SYNDROMES. A SINGLE CENTER DATA.

EHA Library, Sonia Cismas, 216362

THE PREDICTIVE VALUE OF FERRITIN, FOLIC ACID AND VITAMIN B12 AS BIOMARKERS FOR THE DEVELOPMENT OF LEUKEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES. A PILOT STUDY

EHA Library, Diana Lighezan, 216363

STUDY ON QUALITY OF THE TRANSFUSION PROCESS IN OUTPATIENT CARE IN A TERTIARY HOSPITAL

EHA Library, Borja CIDONCHA MORCILLO, 216364

NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET COUNT AS PROGNOSTIC INDEX IN MYELODYSPLASTIC SYNDROME

EHA Library, Inga MANDAC ROGULJ, 216366

CHARACTERISTICS AND SURVIVAL OF DIABETIC AND NON-DIABETIC PATIENTS WITH MYELODYSPLATIC SYNDROMES.

EHA Library, Yakir Moshe, 216367

FLOW CYTOMETRIC CHARACTERIZATION OF THE CD4 AND CD8 T CELL IN MDS – IS IT CLINICALLY RELEVANT?

EHA Library, Aisha arshad, 216368

CLINICAL IMPLICATION OF SERUM FERRITIN LEVEL AT DIAGNOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES.

EHA Library, Masayuki SHISEKI, 216369

MIR-16 IS ASSOCIATED WITH VEGF UPREGULATION IN HIGH-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Yanbo Nie, 216370

ASIA-INCLUSIVE CLINICAL DEVELOPMENT OF PEVONEDISTAT IN COMBINATION WITH AZACITIDINE IN HIGHER RISK MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR LOW-BLAST ACUTE MYELOID LEUKEMIA

EHA Library, Xiaofei Zhou, 216371

UNUSUAL FAVOURABLE CLINICAL COURSE IN A PATIENT WITH LOW-RISK MYELODYSPLASTIC SYNDROME WITH DEL (5Q) AND ACQUIRED TP53 MUTATION: CLINICAL, BIOLOGICAL AND MOLECULAR SEQUENTIAL STUDY

EHA Library, Carlo Finelli, 216372

HEALTH IMPACT OF THE 5-AZACYTIDINE ADMINISTRATION IN THE DOMICILIARY CARE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Carolina Alarcón-Payer, 216373

EVALUATION OF THE EFFICACY OF LENALIDOMIDE IN PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS) WHO ARE PARTIALLY RESISTANT TO HYPOMETHYLATING THERAPY

EHA Library, Galina Dudina, 216374

IS MDS REALLY TREATABLE? EXPERIENCE FROM PAKISTAN

EHA Library, Nida Anwar, 216375

EPIDEMIOLOGICAL, CLINICAL AND GENETIC CHARACTERIZATION OF APLASTIC ANEMIA PATIENTS IN PAKISTAN

EHA Library, Zaineb Akram, 216376

HOW USEFUL IS CD14 AND CD64 FOR GATING MONOCYTES IN FLOW CYTOMETRIC STUDY FOR PROXIMAL NOCTURNAL HEMOGLOBINURIA?

EHA Library, Woo-Jae Kwoun, 216377

AN UNUSUAL CASE OF PURE RED CELL APLASIA

EHA Library, Moon Ley Tung, 216378

DISTINCT DYNAMICS OF PNH CLONE AND HEMOLYTIC MANIFESTATIONS ACCORDING TO BASELINE CLONE SIZE IN PATIENTS WITH APLASTIC ANEMIA/PNH AFTER IMMUNOSUPPRESSIVE TREATMENT: PROSPECTIVE OBSERVATIONAL STUDY

EHA Library, Sung-Soo Park, 216379

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ADULTS - A RETROSPECTIVE ANALYSIS FROM A SINGLE INSTITUTION

EHA Library, Maciej Machaczka, 216380

ELTROMBOPAG FOR THE TREATMENT OF APLASTIC ANEMIA – CROATIAN EXPERIENCE

EHA Library, Drazen Pulanic, 216381

BREAKTHROUGH HEMOLYSIS AND THROMBOEMBOLISM CONTROLLED BY ECULIZUMAB DURING PREGNANCY IN PAROXYSMAL NOCTURAL HEMOGLOBINURIA (PNH): A SINGLE INSTITUTION EXPERIENCE

EHA Library, Chiara FRAIRIA, 216382

FOUR CASES OF FANCONI ANEMIA WITH VARIABLE ABNORMALITIES

EHA Library, Emine TURKKAN, 216383

PIGA MUTATIONS AS A PREDICTORS OF TREATMENT RESPONSE IN PNH

EHA Library, Hee Sue Park, 216384

CHRONIC PRIMARY NEUTROPENIA IN ADULTS. A MONOCENTRIC UNIVERSITY HOSPITAL COHORT STUDY

EHA Library, Linet Njue, 216385

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN CHILDHOOD AND ADOLESCENCE- A 5-YEAR RETROSPECTIVE ANALYSIS FROM A SINGLE TERTIARY CARE CENTER FROM NORTH INDIA.

EHA Library, Rohan Halder, 216386

CLINICAL OUTCOMES IN ADULT PATIENTS WITH APLASTIC ANEMIA: A SINGLE INSTITUTION EXPERIENCE.

EHA Library, Yavor Petrov, 216387

ELTROMBOPAG’S ADDITIVE VALUE IN THE THERAPY OF PEDIATRIC ACQUIRED APLASTIC ANEMIA: A SINGLE INSTITUTION EXPERIENCE

EHA Library, Maria Filippidou, 216388

BEST PRACTICE GUIDANCE FOR NURSES MANAGING PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA ACROSS THE LIFE SPECTRUM

EHA Library, Louise Arnold, 216389

A COMPARISON OF THE ACCURACY IN DETECTING MINOR PNH CLONES IN PATIENTS WITH BONE MARROW FAILURE BETWEEN TWO HIGH-SENSITIVITY FLOW CYTOMETRY ASSAYS: CLSI AND OPTIMA

EHA Library, Kohei Hosokawa, 216390

BONE MARROW FINDINGS IN COLLAGEN VASCULAR DISEASES ASSOCIATED WITH CYTOPENIAS

EHA Library, Doaa elshamy, 216391